Healthcare AI is moving from experiments to the financial and clinical machinery that keeps hospitals running. In a three-day stretch, AKASA, Autonomize, and Galiark announced platforms aimed at medical coding, clinical documentation, claims, appeals, and revenue cycle operations.
The timing is striking. Healthcare organizations face rising coverage costs, coding errors, insurer denials, and huge volumes of claims work, while new AI systems promise to turn hours of review into minutes of structured decisions.
AKASA Targets the Inpatient Coding Bottleneck
On October 2, 2026, AKASA announced an autonomous AI platform for inpatient medical coding and clinical documentation integrity. The healthcare AI company says its products support more than $180 billion in aggregate net patient revenue and roughly 10% of U.S. inpatient discharges.
The platform arrives as hospitals face a difficult coding workload. A 2025 peer-reviewed study reported medical coding error rates of up to 20%, and 60% of hospital systems had begun using AI coding tools. AKASA’s AI products processed inpatient volume that had grown almost 6x in the year before the launch, showing how fast demand for these systems has expanded.
Speed is the central promise. AKASA’s system can code an encounter in 90 seconds, compared with 30 to 60 minutes for a human coder. That gap could reshape how hospitals handle inpatient documentation, especially when large volumes require review before billing and reimbursement can move forward.
“For years, an autonomous mid-cycle has been a holy grail in our industry. Today, AKASA is making it real,” said Malinka Walaliyadde, CEO and co-founder of AKASA.
That promise is colliding with a debate over how AI-assisted coding affects health plan costs. The Blue Cross Blue Shield Association estimated that AI-assisted medical coding contributed to nearly $1 billion, or $942 million, in additional costs for its health plans between 2023 and 2025. BCBSA said roughly 70% of the billing it identified, equal to $653 million, involved diagnoses not accompanied by a change in care.
The American Hospital Association criticized BCBSA’s analysis and said AI tools help providers capture patient conditions appropriately. Vanessa Moldovan, head of RCM strategy at Magical, said AI can help providers respond to insurer denials, document and code care, and challenge those denials.
Context AI Connects Clinical and Operational Evidence
Autonomize announced the general availability of Autonomize Context AI™ on October 1, 2026. The platform combines healthcare-native ontologies, clinical and operational knowledge, enterprise-specific rules, and provenance-backed reasoning, creating a foundation for decisions that must connect patient information with business processes.
Autonomize organizes its platform into two layers:
- Context Graph: a layer for healthcare-native ontologies, clinical and operational knowledge, and provenance-backed reasoning.
- Enterprise Extensions: a layer for enterprise-specific rules and operational workflows.
The system is already powering healthcare operations across utilization management, benefit configuration, payment integrity, claims, appeals, grievances, and pharmacy management. Autonomize reports 55% faster clinical reviews, 60% faster decision turnaround, and a 3–5x return on investment within 6–12 months.
Ganesh Padmanabhan, CEO and co-founder of Autonomize, and Laksh Krishnamurthy, CTO of Autonomize, are bringing Context AI into a market where every decision can depend on evidence, policy, and a traceable record of how the result was reached.
The pressure is clear: U.S. healthcare claims denials and appeals cost approximately $307 billion annually. As coverage costs are forecast to rise 8.2% on average in 2027, the highest forecast since 2003, systems that connect documentation with payment decisions will face intense demand.
Galiark Brings Deterministic AI to Claims
On September 29, 2026, Galiark announced the launch of its deterministic AI platform in the U.S. healthcare claims market. The AI infrastructure company says its technology can increase claims processing capacity by approximately 15–22 times before human review, giving claims teams a larger automated first pass without removing human oversight.
Galiark’s engine requires approximately eight minutes to process a claim, compared with two to three hours of human work. In one demonstration of its scale, the platform processed 2.5 million dispute records in 267 seconds and encoded the entire Federal IDR rule family.
That design focuses on repeatable reasoning rather than open-ended answers. “Most AI products start with a prompt and produce an answer. Our deterministic engine is designed to reason across evidence, regulation, policies, relationships and events while preserving a complete audit trail,” said Tom Bennett, co-founder and joint CEO of Galiark.
Dr. Max Gohmann, co-founder and chief revenue officer of Galiark, said, “Healthcare gives us a defined group of clients and a clearly measurable unmet need.”
Across coding, documentation, claims, and appeals, these platforms point toward a healthcare revenue cycle built around faster processing and stronger evidence trails. The next test will be whether hospitals, insurers, and other healthcare organizations can turn that speed into accurate decisions, clearer documentation, and fewer costly disputes.
Based on
- AKASA Brings Autonomous AI to Inpatient Coding and Clinical Documentation — unite.ai
- AI is inside the healthcare billing system. It may be costing patients — cnbc.com
- Autonomize Introduces Autonomize Context AI™, the Missing Context Foundation That Makes AI Agents Grounded, Useful, and Scalable for Healthcare Enterprises | Markets Insider — markets.businessinsider.com
- Galiark Launches Deterministic AI Platform for U.S. Healthcare Claims Market | Markets Insider — markets.businessinsider.com
